Page last updated: 2024-08-25

rosiglitazone and Co-infection

rosiglitazone has been researched along with Co-infection in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alcorn, JF; Forno, E; Gopal, R; Grousd, JA; Marinelli, MA; McHugh, KJ; Mendy, A; Patel, S; Rich, HE; Richwalls, LJ; Seger, PJ	1

Other Studies

1 other study(ies) available for rosiglitazone and Co-infection

Article	Year
Peroxisome Proliferator-Activated Receptor Gamma (PPAR) Suppresses Inflammation and Bacterial Clearance during Influenza-Bacterial Super-Infection. Viruses, 2019, 06-01, Volume: 11, Issue:6 Topics: Animals; Bacterial Infections; Coinfection; Cytokines; Diabetes Mellitus, Type 2; Female; Gene Expression Regulation; Humans; Inflammation; Influenza A Virus, H1N1 Subtype; Influenza, Human; Interferons; Lung; Male; Methicillin-Resistant Staphylococcus aureus; Mice; PPAR gamma; Rosiglitazone; Signal Transduction; Viral Load	2019

Article

Year

Peroxisome Proliferator-Activated Receptor Gamma (PPAR) Suppresses Inflammation and Bacterial Clearance during Influenza-Bacterial Super-Infection.

Viruses, 2019, 06-01, Volume: 11, Issue:6

Topics: Animals; Bacterial Infections; Coinfection; Cytokines; Diabetes Mellitus, Type 2; Female; Gene Expression Regulation; Humans; Inflammation; Influenza A Virus, H1N1 Subtype; Influenza, Human; Interferons; Lung; Male; Methicillin-Resistant Staphylococcus aureus; Mice; PPAR gamma; Rosiglitazone; Signal Transduction; Viral Load

2019